Status:
COMPLETED
I-gel Plus Supraglottic Airway Device for Surgical Procedures in Prone Position
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
General Anesthesia
Airway Management
Eligibility:
All Genders
18-89 years
Brief Summary
I-gel Plus is a novel supraglottic airway device that has been evaluated in various studies with high success and low complication rates. Feasibility of supraglottic airway devices (SGA) in patients u...
Eligibility Criteria
Inclusion
- Patients scheduling for elective surgery in prone position
- Planned airway management using a SGA
- Adult patients (age 18-89 years)
- ASA physical status 1-3
Exclusion
- Pregnant or breastfeeding women
- Non-fasted patients
- Increased risk of aspiration or other contraindications for supraglottic mask ventilation
- Shared airway or intracavity open surgery
- Body mass index (BMI) \>35 kg/m2
- Inability to understand or sign informed consent
Key Trial Info
Start Date :
October 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 4 2025
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT06602817
Start Date
October 1 2024
End Date
February 4 2025
Last Update
June 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical-Center Hamburg Eppendorf
Hamburg, Hamburg, Germany, 20246